Judge Strips Ethypharm's Antitrust Suit Over TriCor IP

Law360, New York (August 23, 2011, 8:36 PM EDT) -- A Delaware federal judge on Tuesday dismissed the bulk of Ethypharm SA France's suit accusing Abbott Laboratories of engaging in anti-competitive conduct in connection with a patent fight over Abbott's lucrative cholesterol drug TriCor, just weeks before the case is to go to trial.

Ethypharm brought the suit in March 2008, arguing that agreements Abbott entered with Reliant Pharmaceuticals Inc. — the U.S. distributor for Ethypharm's competing fenofibrate product Antara — were illegal and anti-competitive.

Abbott moved to dismiss the suit, saying its refusal to license...
To view the full article, register now.




Case Information

Case Title

Ethypharm SA France v. Abbott Laboratories

Case Number




Nature of Suit



Sue L. Robinson

Date Filed

March 2, 2008

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.